G1 Therapeutics, Inc. (GTHX)
USD 7.16
(0.14%)
USD 7.16
(0.14%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 82.51 Million | 51.3 Million | 31.47 Million | 45.28 Million | - | - |
| Cost of Revenue | 7.19 Million | 3.74 Million | 2.01 Million | - | 356 Thousand | 175 Thousand |
| Gross Profit | 75.31 Million | 47.55 Million | 29.46 Million | 45.28 Million | -356 Thousand | -175 Thousand |
| Operating Expenses | 114.84 Million | 183.73 Million | 171.91 Million | 141.76 Million | 129.04 Million | 89.28 Million |
| Selling, General and Administrative Expenses | 71.13 Million | 100.41 Million | 95.69 Million | 68.49 Million | 40.03 Million | 18.6 Million |
| Research and Development Expenses | 43.71 Million | 83.31 Million | 76.22 Million | 73.27 Million | 89 Million | 70.68 Million |
| Other Expenses | 2.24 Million | 3000.00 | -346 Thousand | -542 Thousand | 6.59 Million | 3.99 Million |
| Cost and Expenses | 122.03 Million | 187.47 Million | 173.93 Million | 141.76 Million | 129.04 Million | 89.28 Million |
| Operating Income | -39.52 Million | -136.17 Million | -142.45 Million | -96.47 Million | -129.04 Million | -89.28 Million |
| Interest Expense | 10.03 Million | 10.43 Million | 4.66 Million | 1.77 Million | - | - |
| Income Tax Expense | 3.11 Million | 1.7 Million | 925 Thousand | 1.41 Million | -356 Thousand | 3.99 Million |
| Earnings before Tax | -44.85 Million | -145.85 Million | -147.42 Million | -97.84 Million | -122.44 Million | -85.28 Million |
| Net Income | -47.96 Million | -147.55 Million | -148.35 Million | -99.25 Million | -122.09 Million | -85.28 Million |
| Earnings Per Share Basic | -0.93 | -3.38 | -3.54 | -2.62 | -3.26 | -2.56 |
| Earnings Per Share Diluted | -0.93 | -3.38 | -3.54 | -2.62 | -3.26 | -2.56 |
| Weighted Average Shares Outstanding | 51.73 Million | 43.62 Million | 41.94 Million | 37.87 Million | 37.49 Million | 33.31 Million |
| Weighted Average Shares Outstanding (Diluted) | 51.73 Million | 43.62 Million | 41.94 Million | 37.87 Million | 37.49 Million | 33.31 Million |
| Gross Margin | 0.91 | 0.93 | 0.94 | 1.00 | - | - |
| EBIT Margin | -0.47 | -2.63 | -4.54 | -2.12 | - | - |
| Profit Margin | -0.58 | -2.88 | -4.71 | -2.19 | - | - |
| EBITDA | -39.01 Million | -134.89 Million | -142.45 Million | -95.48 Million | - | - |
| Earnings Before Tax Margin | -0.48 | -2.65 | -4.53 | -2.13 | - | - |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 16.54 Million | 14.47 Million | 14.87 Million | 82.51 Million | 12.3 Million | 42.39 Million |
| Cost of Revenue | 733 Thousand | 1.07 Million | 1.25 Million | 7.19 Million | 3.07 Million | 1.4 Million |
| Gross Profit | 15.81 Million | 13.39 Million | 13.61 Million | 75.31 Million | 9.22 Million | 40.98 Million |
| Operating Expenses | 19.34 Million | 22.44 Million | 22.54 Million | 114.84 Million | 28.66 Million | 29.47 Million |
| Selling, General and Administrative Expenses | 13.61 Million | 15.12 Million | 15.16 Million | - | 16.78 Million | 17.43 Million |
| Research and Development Expenses | 5.73 Million | 7.31 Million | 7.38 Million | - | 8.81 Million | 12.04 Million |
| Other Expenses | 567 Thousand | 526 Thousand | 548 Thousand | 2.24 Million | 3.07 Million | 569 Thousand |
| Cost and Expenses | 20.08 Million | 23.52 Million | 23.8 Million | 122.03 Million | 28.66 Million | 30.87 Million |
| Operating Income | -3.53 Million | -9.04 Million | -8.92 Million | -39.52 Million | -16.36 Million | 11.51 Million |
| Interest Expense | 2.72 Million | 1.97 Million | 2.12 Million | 10.03 Million | -2.11 Million | 2.71 Million |
| Income Tax Expense | - | 76.72 Thousand | 902 Thousand | 3.11 Million | 905 Thousand | 1.3 Million |
| Earnings before Tax | -5.46 Million | -10.21 Million | -9.97 Million | -44.85 Million | -17.29 Million | 10.01 Million |
| Net Income | -5.46 Million | -10.21 Million | -10.87 Million | -47.96 Million | -18.2 Million | 8.71 Million |
| Earnings Per Share Basic | -0.10 | -0.20 | -0.21 | - | -0.35 | 0.17 |
| Earnings Per Share Diluted | -0.10 | -0.20 | -0.21 | - | -0.35 | 0.14 |
| Weighted Average Shares Outstanding | 52.47 Million | 52.17 Million | 51.83 Million | 51.73 Million | 51.77 Million | 51.66 Million |
| Weighted Average Shares Outstanding (Diluted) | 52.47 Million | 52.17 Million | 51.83 Million | 51.73 Million | 51.77 Million | 61.04 Million |
| Gross Margin | 0.96 | 0.93 | 0.92 | 0.91 | 0.75 | 0.97 |
| EBIT Margin | -0.21 | -0.62 | -0.59 | - | -1.33 | 0.30 |
| Profit Margin | -0.33 | -0.71 | -0.73 | -0.58 | -1.48 | 0.21 |
| EBITDA | -3.41 Million | -8.92 Million | -8.8 Million | - | -16.36 Million | 12.85 Million |
| Earnings Before Tax Margin | -0.21 | -0.63 | -0.60 | -0.48 | -1.33 | 0.27 |
AGRUF
6H90
002181
6396
6732
ONXYY